High-Intensity MRI Can ID Local Recurrence for Musculoskeletal STS

WEDNESDAY, Feb. 8, 2023 (HealthDay News) -- Magnetic resonance imaging (MRI) used at high intensity can detect clinically occult local recurrences (LRs) for musculoskeletal soft-tissue sarcoma (STS), according to a systematic review published online Jan. 26 in the American Journal of Roentgenology.
Natalia Gorelik, M.D., from the McGill University Health Center in Montreal, and colleagues examined the value of MRI-based surveillance for musculoskeletal STS represented by the proportion of LRs discovered by MRI versus clinically. Electronic databases were searched systematically through November 2022 for controlled trials and cohort studies on the use of MRI-based surveillance. Data were included for 19 studies; all were retrospective cohorts. In addition, the correlation of low- versus high-intensity surveillance on the proportion of LR detected on MRI was assessed.
There was a moderate and high risk for bias in 37 and 63 percent of studies, respectively. The researchers found that the pooled proportion of LRs detected on MRI was 53 and 6 percent with high- and low-intensity surveillance, respectively. Inconsistent results were seen between studies on comparison of LR characteristics detected on imaging versus clinically identified. In four studies, there were trends toward better survival for imaging-detected LRs or more frequent imaging use.
"When MRI is used at a high frequency, it may detect many clinically occult LRs. Trends toward improved survival with imaging-detected LRs or more frequent imaging use were reported in four studies," the authors write. "However, the available evidence consists of small studies with occasionally inconsistent results and substantial risk of bias."
Abstract/Full Text (subscription or payment may be required)
Related Posts
Biden Administration to Offer Second COVID-19 Boosters to Those 50+
MONDAY, March 28, 2021 (HealthDay News) -- Despite not knowing how long another...
El virus de la COVID evoluciona tres veces más rápido en los venados que en los humanos
LUNES, 28 de agosto de 2023 (HealthDay News) -- Las variantes de la COVID-19...
Maker of Diet Drug Wegovy Ramps Up Production to Meet Demand
THURSDAY, Feb. 2, 2023 (HealthDay News) – The wildly popular weight-loss drug...
New Clues to Early Miscarriage and How to Predict Them
MONDAY, March 27, 2023 (HealthDay News) -- Miscarriages are devastating and...